Berlin, Germany

Anja Richter

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 11.5

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Anja Richter: A Trailblazing Inventor in Pharmaceutical Innovations

Introduction

Anja Richter, a prominent inventor based in Berlin, Germany, has made significant contributions to the pharmaceutical field. With a remarkable portfolio of six patents, she has focused on developing innovative compounds aimed at addressing critical health challenges, including cancer.

Latest Patents

Among Anja's latest inventions are groundbreaking compounds that relate to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides. These compounds are instrumental in creating pharmaceutical compositions for the treatment and prophylaxis of a range of diseases, particularly cancer. The general formula highlights the versatile structures inherent to her compounds, which can be modified to enhance efficacy. Additionally, her work on substituted benzylpyrazoles presents new avenues for pharmaceutical applications, showcasing her commitment to innovation in the field.

Career Highlights

Anja Richter has had a successful career with notable companies such as Bayer Pharma AG and Bayer Intellectual Property GmbH. Her extensive experience in these organizations has equipped her with a comprehensive understanding of pharmaceutical development and intellectual property, facilitating her innovative research.

Collaborations

Collaboration has been key to Anja's success. She has worked alongside accomplished colleagues such as Anne Mengel and Marion Hitchcock, contributing to a dynamic and innovative work environment. Their joint efforts have led to the advancement of pharmaceutical research and the successful development of new therapeutic compounds.

Conclusion

Anja Richter stands out as a leading inventor within the pharmaceutical sector, driving forward important innovations that could change the landscape of disease treatment. With her ongoing research and development efforts, she continues to inspire future generations of inventors and researchers dedicated to enhancing human health through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…